NIH-funded research NIH-funded research

Health Resources Core supports clinical and translational research at UofL

Official title: Health Resources (HR) Core

Funded at University of Louisville · NIH-11382438 · Data updated 2026-11-12

A Health Resources core at the University of Louisville helps doctors and researchers work together to turn ideas into real health improvements for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startJuly 10, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$924,073
NIH project number5P20GM155899-03
Project IDNIH-11382438 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients and communities served by CTR-D populations who may benefit from translational research improvements and early-stage clinical projects.

Less likely to help

Some patients may not directly benefit in the early phases if projects are foundational or investigator training-oriented.

What this research studies

This grant funds a Health Resources Core that manages CTR-D research activities, supports two types of projects, and helps early-career investigators gain resources to pursue extramural funding. It focuses on building a robust Clinical and Translational workforce and fostering collaborations between basic science and patient-focused care. The core handles application solicitation, review, and funding decisions, prioritizing projects that involve CTR-D populations or cross-disciplinary teams. By strengthening operational processes and providing pilot and developmental funding, it aims to improve the quality of life for Kentuckians and beyond.

Why it matters

Potential benefit: If successful, patients could see faster translation of research into better clinical care and new treatment options.

How similar studies have gone: Similar translational cores have helped launch pilot projects into independent funding in other institutions, with examples of translating ideas into grant-ready studies.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Mcclain, Craig J. — University of Louisville
  • Study coordinator: Mcclain, Craig J.

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.